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Abstract 
 
Pre-exposure prophylaxis (PrEP) has been hailed as a revolutionary intervention for HIV 
prevention.  PrEP’s controversial status in the UK has generated significant media coverage. 
It is important to understand what role the media plays in framing PrEP policy issues.  We 
undertook a qualitative analysis of UK newsprint articles between 2012-2016 to examine how 
PrEP was framed as a public health intervention up until a controversial policy decision not to 
provide PrEP in England. We identified how scientific evidence was deployed to shape two 
narratives: ir/responsible citizens focused on imagined PrEP users and their capacity to use 
PrEP effectively; and the public health imperative, which described the need for PrEP. Our 
analysis demonstrates the particular ways in which scientific evidence contributed to the 
certainty of PrEP as an effective intervention within UK newsprint. Scientific evidence also 
played a key role in framing PrEP as an intervention specifically for cis-gendered gay and 
bisexual men, playing into wider debates about who is a deserving patient and appropriate 
use of public resources. Practitioners in the UK and elsewhere should be aware of these 
constructions of the PrEP user to ensure equitable access to PrEP beyond gay and bisexual 
men.  
 
Keywords: pre-exposure prophylaxis (PrEP); HIV; media; gender; health inequalities 
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Introduction 
 
In November 2016, the Court of Appeal of England and Wales ruled in favour of a judicial 
review brought forward by the National AIDS Trust (NAT), a UK HIV policy organisation (Court 
and Tribunals Judiciary 2016).  NAT argued that the provision of pre-exposure prophylaxis 
(PrEP) - the use of existing HIV treatment in the form of a (usually) daily pill by HIV-negative 
individuals to prevent the acquisition of HIV -  was within National Health Service (NHS) 
England’s remit of provision (NAT 2016). The ruling ended a very public court battle 
challenging NHS England’s controversial March 2016 policy decision that funding PrEP did not 
fall within its remit.  This public battle garnered significant UK media attention and public 
debate ensued concerning the NHS’s role in funding a drug to prevent HIV amongst gay and 
bisexual men. Grounded in claims that funding this expensive drug would take away from 
essential medicines for more worthy patients (e.g. children, cancer patients), the issue 
focused squarely on the high cost of a lifestyle – and not life-saving – drug that was seen to 
benefit a minority population (gay and bisexual men). The implicit messages, reinforced by 
homophobic undertones reminiscent of early AIDS reporting (Watney 1987), were that gay 
and bisexual men should take responsibility for their own health through condom use and 
behaviour modification rather than relying on expensive, publicly-funded pharmaceuticals 
(Twocock 2016; Duffy 2016; Mowlabocus 2019). Although the ultimate legal resolution 
determined that responsibility for commissioning PrEP lay with NHS England – which would 
come with a new set of controversies – the debate centred around both who PrEP was for 
and the need for PrEP itself.  
Media reporting on biomedical developments allows us to examine how scientific 
evidence itself is deployed, translated and appraised in public spaces.  As we have seen 
throughout the history of HIV, mass media institutions have played ‘a critical role in shaping 
how scientific controversies are interpreted, and adjudicated’ (Epstein 1996:22).  In her work 
on AIDS as a biomedical and a cultural phenomenon, Paula Treichler describes how multiple 
meanings of what we would now term HIV originate, proliferate and take hold, arguing  
 
we need an epidemiology of signification – a comprehensive mapping and analysis of 
these multiple meanings – to form the basis for official definition that will in turn 
constitute the policies, regulations, rules and practices that will govern our behaviour 
for some time to come…as we have seen, these may rest on ‘facts’, which in turn may 
rest on the deeply entrenched cultural narratives (Treichler 1999: 39).  
 
While the scientific evidence for PrEP, including clinical and cost-effectiveness, may 
have been clear to experts prior to the NHS England policy decision being taken (Lancet 2016), 
it is important to understand how evidence was deployed and shaped by wider cultural 
narratives, and to consider the specific role of media in framing these UK-wide health policy 
issues.  In this article, we examine how UK newsprint media reported PrEP as a public health 
intervention prior to the NHS England decision. While the media coverage of PrEP after March 
2016 was steeped in questions around sexuality, responsibility and entitlement, we ask how 
PrEP was configured in newsprint media as a public health intervention up until this point and 
consider how this may have shaped subsequent public PrEP debates. 
 
Framing public health narratives in newsprint 
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The media and its engagement with science and related health research play a key role in 
shaping public understandings of health (Seale 2002).   Indeed, there is long history of critical 
analysis focusing on the cultural politics of HIV and AIDS, and the role of the media in 
representing and constructing understandings of the HIV epidemic, as well as shaping policy 
and public health endeavours (Epstein 1996; Treichler 1999; Watney 1987). The role of 
newsprint in particular as emblematic of mass media, and how it frames health narratives, 
has been well established in the social science literature (McCallum and Holland 2017; 
Pickersgill et al. 2017; Williams et al. 2008; Hilton et al. 2010).   
In this article, we examine newsprint media as a discursive site, recognising the role it 
plays in shaping understandings of public health and related technologies, but also in how it 
engages more directly with wider public health and/or scientific imaginaries (Davis 2014). Like 
Pickersgill et al., (2017) we explore how newsprint articles ‘imagine and articulate’ 
understandings of science within a UK context. It is important to note that this relationship – 
between media and publics – is mediated by the ways in which media, scientific, health and 
community stakeholders interact (Briggs and Hallin 2016 ; McCallum and Holland 2017). In 
their book Making Public Health, Briggs and Hallin (2016) draw on the concept of 
biomedicalisation  (Clarke et al. 2010) to describe how media and public health actors interact 
with each other in an increasingly technoscientific era.  At a time when media outlets commit 
fewer resources to producing science- or health-based stories (Stansistreet 2015), public 
health and research institutions are increasingly investing in media specialists to 
communicate and tailor research findings for wider publics, including media outlets. 
Biomediatisation, Briggs and Hallin argue, results in a shift from reporting to forms of co-
producing news stories. Moreover, as these new mediated communications relationships 
adapt to ‘the logics and routines of news media to get their message across, they may gloss 
over the complexities and contingencies of scientific knowledge’ (McCallum and Holland 
2017). For the purposes of this paper, it is imperative therefore to consider not only who is a 
part of creating these public health narratives, but on what evidence they are based and how 
this evidence is deployed to produce PrEP itself. In other words, the very nature of what PrEP 
is as an intervention is constituted through these configurations of evidence (Rosengarten 
2010; Montgomery 2012). 
This article also considers how the technology user is shaped in or through how the 
technology itself is imagined or conveyed (Montgomery 2012; Johnson 2017). Oudshoorn et 
al argue that ‘a semiotic approach to user-technology relations enables us to analyse how, 
even in cases where users are not formally involved in the design, technologies may become 
adjusted to certain groups of users because of the incorporation of specific images of the 
future users’ (Oudshorn, Rommes, and Sinestra 2004). That is, the end user of a particular 
technology, including a pharmaceutical intervention, is already imagined and shaped 
throughout the design and/or implementation of the technology itself. However, the user and 
technology interact with and reconfigure each other to co-constitute technologies. As a 
result, we need to consider the ways in which end-users are imagined and re-imagined as 
technologies are deployed (Montgomery 2012). We draw on and add to the work of  Holt, 
who has explored how the PrEP user is configured, in an earlier PrEP era, through scientific 
writing (Holt 2014).  Holt focused on how PrEP was configured specifically for gay and bisexual 
men through research trial products (e.g. articles, testimonies). While Holt looked primarily 
at US research, we consider the imagined use of PrEP as told through UK newsprint, paying 
particular attention to who the PrEP user might be, and if and how they may be gendered 
(Johnson 2017; Montgomery 2012). 
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In exploring PrEP and its imagined users in UK newsprint, we also engage with the 
wider biomedicalisation of HIV (Young, Flowers, and McDaid 2016). The increasing move to 
biomedical HIV prevention interventions globally has not been without controversy. 
Opposition to biomedicalisation of HIV prevention related not only to concerns around costs 
of pharmaceuticals and fear of technologies, but also the erasure of social practices which 
have been instrumental in maintaining prevention (and care) practices throughout the HIV 
epidemic (Kippax and Stephenson 2012; Nguyen et al. 2011). Understanding how scientific 
evidence of efficacy and effectiveness is deployed within this contested space is critical. 
Throughout the epidemic, scientific evidence has been used to shape particular ends and has 
itself been shaped by social norms and values (Epstein 1996; Treichler 1999). Paying attention 
to how and where scientific narratives of health and prevention emerge in relation to PrEP is 
also about exploring how PrEP is framed in relation to wider histories of social and health 
inequalities. 
 
Methods 
 
We employed a qualitative content analysis approach by undertaking thematic analysis of the 
latent content of newspaper articles (Altheide 2012). Latent content refers to the underlying 
meaning of texts, which demands an interpretative coding approach (Neuendorf and Kumar 
2006).  
We selected 16 mainstream, UK national daily and Sunday newspapers with high 
circulations (Press Gazette 2016), and four Scottish national newspapers, representing a 
broad range of newsprint readership profiles: The Daily Mail and The Mail on Sunday; The 
Daily Telegraph and  The Sunday Telegraph; The Express and  The Sunday Express; The 
Guardian and The Observer; The Independent and The Independent on Sunday; The Mirror 
and The Sunday Mirror; The Times and The Sunday Times; The Sun; and Metro; The Herald & 
Sunday Herald; The Scotsman & Scotland on Sunday; The Daily Record and Sunday Mail; and 
The National. The Sunday counterpart of The Sun was not archived in the Nexis database used, 
and Metro does not have a Sunday counterpart.  
This sampling frame includes publications from different newspaper ‘genres’ (tabloid, 
middle-market tabloid and serious), employing a typology used previously (e.g. Hilton et al. 
2010; Patterson, Hilton, and Weishaar 2016) to ensure a sample of publications representing 
a demographically diverse range of newsprint reading audiences. Content included material 
available through online newsprint coverage.  
Our search period started on 1 January 2012, the year that PrEP was approved by the 
US Food and Drug Administration (FDA) and covered a period during which PrEP became 
recognised globally as a viable HIV prevention tool. We ended our search on 31 March 2016, 
the point at which NHS England announced their decision not to fund PrEP. This end point 
allowed us to focus on how PrEP was configured as an intervention through the media before 
debates moved more explicitly towards issues of entitlement.  Using the Nexis database, we 
searched for articles that either contained ‘HIV’ and/or ‘AIDS’ within five words of the term 
‘pill’ or contained one or more of the following terms: ‘Pre-exposure prophylaxis’; ‘Truvada’; 
‘anti-aids’; ‘anti-HIV’; ‘HIV drug’; and ‘AIDS drug’. All articles that matched the search string 
were downloaded and subjected to initial review. This yielded 156 articles. To ensure that 
only articles predominantly reporting on PrEP were included, any articles of which more than 
50% of the text was not relevant to PrEP were excluded. We excluded 109 articles at this stage 
resulting in a sample of 47 articles for full review.  
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All articles were initially read by the first and second authors to generate broad 
thematic categories (Table 1). Articles were systematically read and coded according to these 
thematic categories, including recording general interpretative notes about each article, by 
authors one, two and three. At this stage, three more articles were excluded, providing a final 
sample size of 44 (See Table 2).  Only 2 articles came from Scottish newspapers, with the 
remaining 42 from mainstream UK national newspapers. No separate analysis was 
undertaken on the Scottish articles due to small numbers. To promote consistency, one 
quarter of the articles were double-coded, and coders discussed their interpretations of the 
thematic categories throughout.  Once coding was complete, authors one, two and three 
employed both a deductive and inductive approach to analysis by reflecting on article coding, 
but also drawing on a grounded theory approach to consider which stakeholders were 
included in the articles, what was reported, and how it was presented. Through multiple, 
iterative discussions, two broad narratives and a timeline of key PrEP narrative events was 
identified.  
 
Tables 1 and 2 about here 
 
Findings 
 
Although our search period covered more than 3 years (2012-2016), we found relatively few 
newsprint articles on PrEP. We also found very little difference in tone or coverage between 
different genres of newspaper.  Reporting during this period was largely in response to the 
publication of UK and international scientific findings, conference presentations, and/or 
policy decisions. In particular, our analysis identified the release of results from PROUD – a 
UK based PrEP randomised control trial (RCT) with gay and other men who have sex with men 
(MSM) in England – as a central scientific event in patterns of reporting in UK newsprint. It 
was possible to identify two distinct time periods in PrEP reporting: Priming for PROUD, 15 
articles from July 2012 to October 2014 and; the Post PROUD period from February 2015 to 
the end of March 2016, 29 articles, two-thirds of the sample.  The beginning of the Post 
PROUD period, which followed three months in which no reporting on PrEP was identified, 
began with reporting on the presentation of UK PrEP trial PROUD findings at the International 
Conference on Retroviruses and Opportunistic Infections (CROI), a key HIV scientific 
conference. From February 2015 onwards, reporting substantially changed in focus and tone.    
We also identified two broad narratives. The first narrative, ir/responsible citizens, 
focused on PrEP users and their capacity and responsibility to use PrEP correctly, which 
framed the un/certainty of PrEP as an effective intervention. The second narrative, the public 
health imperative, described if and why PrEP might be needed as a public health intervention. 
There was a marked difference in both themes in the two time periods, which we explore 
below (Table 3).  
 
Table 3 about here 
 
Ir/responsible citizens: Priming for PROUD  
 
During this period, imagined PrEP users and their sexual practices were presented as a source 
of unknown or increased risk were PrEP to be made available. Descriptions focusing on 
potential reduction in condom use and its assumed related increases in harms (e.g. increased 
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risk of HIV and STIs) characterised PrEP users as irresponsible. While not always the dominant 
message, this narrative was consistently present. Regular, ongoing constructions of 
irresponsible PrEP users were juxtaposed with, and in some cases part of ,expert opinion and 
reporting on scientific findings. Familiar stereotypical language (Watney 1987) used to paint 
PrEP users as irresponsible citizens included ‘unsafe sex’ when describing condomless sex, 
calling PrEP a ‘party drug’, and describing ‘increased risk taking’, ‘promiscuity’ and/or a 
‘reduction of condoms’. 
Voices from community opposition to PrEP were used to air many of these concerns. 
Quotes evidencing opposition to PrEP came mainly from the AIDS Healthcare Foundation, a 
US organisation known for strong opposition to PrEP, with its founder Michael Weinstein by 
far the most quoted voice. Weinstein and other community voices argued that the provision 
of PrEP would lead to a ‘false sense of security’ (Daily Mail, 17 July 2012) and threaten condom 
use, the most reliable prevention measure against HIV. The irresponsible citizen narrative 
highlighted specific problems which would cause the ‘failure of PrEP’.  In many articles, PrEP 
failure was characterised by poor adherence, in which people were imagined not to take PrEP 
regularly because of forgetfulness or side effects. However, the dominant failure comprised 
forms of ‘risk compensation,’ where PrEP would facilitate an increase in STIs (and possibly 
HIV) because of reduced condom use, and an assumed change in sexual practice to increased 
sexual partners and ‘risky behaviours’.  
In some articles, key UK scientific or community HIV experts refuted or tempered the 
ir/responsible characterisation of the imagined PrEP user. While Professor Sheena 
McCormack, head of the UK PROUD trial, expressed concern about encouraging ‘risky sexual 
behaviour’, she was also reported as providing examples or situations in which condom use 
might not be possible, and explaining how PrEP could be about ‘helping people to be 
responsible’ in these cases (The Times, 17 October 2014).  Similarly, Justin Harbottle from a 
well-known HIV charity, Terrence Higgins Trust (THT), described fears around PrEP as 
‘misplaced’, and compared PrEP to the contraceptive pill, highlighting the need for choices of 
prevention method (Independent, 17 May 2014).  In spite of these tempered comments, 
reporting in most articles cast doubt on the capacity or willingness of PrEP users to act 
responsibly and use PrEP correctly, thus potentially undermining PrEP’s effectiveness to 
prevent HIV. 
 
Ir/responsible citizens: Post-PROUD 
 
With the presentation of PROUD results in February 2015, there was a noticeable shift in the 
representation of imagined PrEP users. In contrast to the sustained focus on the potential 
failure of PrEP users in the earlier period, specific mention of PrEP users and their capacity to 
use PrEP was largely absent. Instead, comment was offered on the use of PrEP and ongoing 
use of condoms, suggesting the capacity of PrEP users to act ‘responsibly’.  
 
A study of British men showed that they were willing to take the pill, which did not 
appear to encourage unsafe sex….. It is allowing individuals to negotiate what sort of 
sex they want. It provides them with protection. (The Times, 25 February 2015) 
 
Although articles continued to refer to condomless sex as ‘unsafe’, there was a marked 
absence of reporting on the potential for ‘irresponsible’ sexual practice.  One article, reporting 
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the PROUD study findings published in The Lancet, addressed these previous concerns 
directly. 
 
A key concern has been that Truvada would become a "party drug", used instead of 
condoms to prevent infection, thereby having the unwanted side-effect of increasing 
the risk of passing on other sexually transmitted infections. But this, it turns out, has 
not been the case - there was no significant increase in other STDs recorded during 
the Lancet trial. (Independent, 11 September 2015) 
 
Other articles, while not refuting a previous stance outright, used more neutral 
language in their reporting.  
 
Since PrEP does not work all the time, nor does it prevent sexually transmitted 
infections like syphilis and gonorrhoea, health authorities say people should continue 
to use condoms regularly. (Telegraph, 24 February 2015) 
 
Instead of focusing on specific users, articles reminded readers that PrEP did not 
prevent STIs, rather than undermine PrEP as an intervention itself. 
 
A small minority of articles raised the issue of the potential of decreased condom use 
and increased STIs if PrEP were made available, but this was often tempered by, or refuted 
with, evidence from the PROUD study: 
 
Men taking part in the study reported they did not change their condom use because of 
PrEP - evidence that was borne out by the fact that infection rates of other STIs were 
similar in both groups. (Independent, 25 February 2015) 
 
Of the 29 articles from this period, there were two notable exceptions to this portrayal 
of imagined PrEP users. Similar to the irresponsible citizen theme in the earlier period, two 
articles described concerns around promiscuity or ‘riskier sex without condoms’ (Daily Mail, 
26 February 2015). Both reported or asked directly if PrEP would ‘encourage risky sex’ (The 
Times, 14 January 2016), with one article referencing US criticisms.  However, both articles 
also reported evidence from PROUD showing no increase in STIs between the PrEP and 
deferred arms of the study. The tone of these articles was more negative, as the articles’ 
structure diminished this evidence, focusing instead on potential risks of PrEP. The tone and 
emphasis of these articles, however, were not in keeping with most articles from this time 
period. 
Voices from community activists and PrEP users were largely absent during this 
period. This meant that although Weinstein’s opposition was no longer present, neither were 
there community voices discussing the potential for PrEP.  This scientific discussion 
contrasted with the narratives around PrEP users present in the earlier period. The absence 
of comment on, or tempered representation of, potential risks from PrEP - thanks in large 
part to the PROUD findings - resulted in a diminishing of the irresponsible citizens narrative 
and a shift towards a potentially effective intervention itself.  
 
Public health imperative: Priming for PROUD  
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Articles in the early period consistently provided general estimates of HIV diagnoses in UK, 
USA or globally. Descriptions included total numbers of HIV diagnoses and expected yearly 
diagnoses. Some, especially of the UK epidemic, also referenced the number of people 
estimated to be undiagnosed.: ‘… 96,000 people in the UK are currently living with HIV. Of 
these people, 22,600 are thought to be unaware of their infection’ (Daily Mail, 13 June 2013). 
Some articles went on to identify groups most at risk of, or affected by, HIV. This often 
included a list of groups including gay and bisexual men, people in relationships with someone 
living with HIV, and people who inject drugs. 
 
Of the 6,280 new cases of HIV in 2011, around 48% were infected through 
heterosexual sex, and 48% through sex between men…. The CDC now estimates as 
many as 275,000 uninfected gay men and 140,000 heterosexual couples, in which one 
partner is HIV-infected, could benefit from PrEP. (Daily Mail, 17 May 2014 ) 
 
With the announcement in October 2014 that the PROUD trial would be offering PrEP 
to all participants, including those on the deferred arm, the presentation of epidemiological 
evidence shifted noticeably. Articles began to include information about HIV rates which 
more obviously focused on the specific benefit of PrEP for gay and bisexual men. 
 
Nearly 100,000 people are living with HIV in the UK. Sex without a condom is the most 
common means of infection. Nearly half of all new infections are among men who 
have sex with men. (Independent, 30 October 2014 )  
 
Some articles addressed the cost of PrEP as they explored the need for the 
intervention. Available at the time only as patented drugs, PrEP was reported as very costly. 
One article outlined that ‘the drug is likely to raise questions over its high price’ (The Times, 
10 February 2014), indicating that it may not be a cost-effective intervention. Other articles 
towards the end of the period outlined similar concerns but indicated that there may be ways 
around the normally prohibitive pricing.  
 
If the final results are good, public-health experts hope the drug could be made 
available on the NHS to those at high risk, although negotiations would have to take 
place with manufacturer Gilead to find a price the health service can afford. The drug 
can cost the equivalent of £7,500 a year in the US. (The Guardian, 18 October 2014) 
 
High cost combined with a more general framing of HIV as a public health issue, rather 
than for a specific group, presented uncertainty in PrEP as a viable intervention, ready for 
implementation.  
 
Public health imperative: Post-PROUD 
 
By February 2015, and the announcement of PROUD findings at CROI, the presentation of any 
HIV context in the articles now focused almost entirely on gay and bisexual men in the UK.  
Articles included specific information on existing HIV rates amongst this group, and the 
potential numbers of gay men who could benefit from PrEP. 
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Men who have sex with other men are most at risk of HIV, accounting for nearly half 
of the 6,000 new cases each year. One in 26 gay men in the UK estimated to have the 
disease, rising sharply to one in eight in London. (Daily Mail, 14 January 2016) 
 
Noticeably absent from most articles were references to other groups for whom PrEP 
might be helpful. This was in stark contrast to articles from the earlier time period. There was 
no mention of trans* communities in spite of being disproportionately affected by HIV (Baral 
et al. 2013). We note, therefore, that references to gay and bisexual men were largely, if not 
exclusively, made with cis-gendered gay men in mind. 
Exceptionally, a very small number of articles from this time period did not present 
PrEP as a public health need in the same way.  Two articles from the Times continued to 
provide a broader HIV context.  One, which reported the modelled effects of PrEP on HIV 
infection rates amongst gay men in the UK, raised the need for attention to ‘other at-risk 
groups’:   
 
[…] if all gay men were offered it, infection rates would fall by 59 per cent, preventing 
10,000 cases of HIV by 2020. Even if it were limited to the quarter of gay men who 
have more than one new sexual partner a year, 7,400 cases would be prevented…. 
What about women and others at risk of HIV? Women with an HIV-positive partner 
are likely be included. Gay men will be prioritised because they are high-risk, easy to 
identify and those coming to clinics are keen to protect themselves. Evidence of 
effectiveness is also stronger. Other at-risk groups, such as some African communities 
and drug users, will be considered later. (The Times, 14 January 2016) 
 
A third article, which described new modes of PrEP delivery, such as vaginal rings and 
injectable PrEP, described how ‘vaginal transmission accounts for the majority of new HIV 
infections across the world.’ (Daily Mail,  21 March 2016).  
The public health imperative theme during this period also drew on cost to frame PrEP 
certainty and need. Whereas earlier reporting focused on the expense of PrEP, reporting here 
drew on the cost-effectiveness of PrEP as an intervention to prevent HIV.  Articles 
acknowledged ongoing high costs of PrEP, but described how such an effective intervention, 
if used by the most appropriate PrEP users, would result in longer term savings to the NHS.  
 
[…]it will have to consider whether the pills, which will cost £423 per month for each 
patient, will be cost-effective, and what the criteria should be for accessing them…If 
we can stop people getting HIV by giving them PrEP, we have an ethical duty to do so. 
Furthermore, over the course of their lifetime the treatment of those 19 men will cost 
the NHS nearly £7m. So the financial argument is clear, as is the ethical one. PrEP 
needs to be available on the NHS as soon as possible for all those who need it. 
(Independent, 25 February 2015) 
 
The imperative for PrEP was also captured in specific language used by public health 
experts. Articles frequently and repeatedly drew on THT Medical Director Dr Michael Brady’s 
description of PrEP as a ‘game-changer’, encapsulating the need for PrEP as a significant tool 
with which to combat the current, and urgent, HIV epidemic amongst gay and bisexual men 
in the UK. With such an effective intervention that would save the NHS money in the longer 
term, the public health imperative to implement this ‘game-changing’ intervention was clear.  
 11 
 
Discussion 
 
In an era of increasing pharmaceutical prevention-based policies and the need to understand 
what shapes policy implementation, our analysis illustrates how specific forms of scientific 
evidence about PrEP were deployed within UK newsprint, playing an important role in the 
configuration of imagined PrEP users. Coverage during this period mobilised scientific 
evidence, first to characterise PrEP as an uncertain intervention in the context of an ongoing, 
global epidemic and, ultimately, to frame PrEP as much needed, ‘game-changing’ public 
health intervention specifically for gay and bisexual men. Reporting initially queried the 
capacity of individuals to use PrEP appropriately, drawing on well-rehearsed stereotypes to 
suggest that irresponsible sexual practice would threaten the effectiveness of the 
intervention. However, PROUD trial results were used to show that PrEP users had the 
capacity to act as responsible citizens (Young et al. 2019). This shift in reporting and 
diminishing doubt about PrEP use added weight to the certainty of PrEP as a feasible and 
effective intervention within these UK media narratives. 
The use of community and scientific voices was key in the framing of evidence (Briggs 
and Hallin 2016 ). The inclusion of community voices and some opposition in the early period 
framed PrEP as an uncertain intervention. This opposition – along with most community 
voices – disappeared from newsprint sources with the success of PROUD, as the role of 
scientists, clinicians and policy makers took centre stage.  Drawing on scientific evidence, such 
as Randomised Control Trial findings, epidemiological need and cost-effectiveness modelling, 
the articles wove a story of need for PrEP as new HIV prevention, primarily for gay and 
bisexual men in the UK. In spite of ongoing global epidemiological need, UK newsprint framing 
of PrEP narrowed in on specific communities, excluding the possibility of wider user and went 
some way to close down the possibility of the intervention as something of use to the general 
population. Unlike new cancer treatments or other interventions that would impact the wider 
population, PROUD results were mobilised here to confirm the effectiveness of the 
intervention for gay men (Holt 2014). Our analysis focused exclusively on newsprint media, 
without reference to social media coverage of PrEP; however, the shift between community 
and clinician to clinician/scientist within this reporting reflects a closing down of who is 
creating the story of PrEP and how this might reflect and/or influence – or certainly frame – 
the imagined PrEP user in wider cultural narratives that affect policy (Treichler 1999).  
Our analysis adds to a relatively small body of PrEP media analyses during a similar 
period (Card et al. 2019; Mowlabocus 2019; Jaspal and Nerlich 2016) by showing how 
scientific evidence was deployed to shape both the reliability of the intervention and to 
construct PrEP users. Jaspal and Nerlich (2016) investigate PrEP newsprint coverage during 
an overlapping period (2008 – 2015), illustrating the use of either highly positive or highly 
negative representations of PrEP through narratives of hope or risk. Looking explicitly at how 
PrEP is anchored and how this might affect uptake of PrEP, they argue that this polarisation 
could close down nuanced and realistic understandings of PrEP for potential users. Our 
analysis, incorporating coverage of PrEP one year after the PROUD findings, found that 
narratives of hope and risk were only part of the story; we found that intervention 
effectiveness (and certainty), epidemiological need and cultural narratives of responsible 
sexual practice played an important role in how PrEP users were configured. Mowlabacus’ 
(2019) explicitly considers how homonormativity is deployed during a period which 
incorporates coverage of the post-NHS England policy decision and highlights the persistence 
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of well-rehearsed stereotypes of gay men. Findings show how these stereotypes were largely 
absent during the period the Post-PROUD, suggesting that the media deployment of PrEP 
evidence tempered – for a time – these familiar, homophobic tropes.  While many of these 
articles - either explicitly or implicitly - explore PrEP in relation to LGBT identities and sexual 
practices, we argue that attention needs to be paid to the deployment of scientific evidence 
and its specific role in shaping who PrEP was for.  
By mapping articles against key scientific events, we illustrate how reporting of 
particular scientific findings plays a key role shaping narratives around new public health 
interventions. We argue that this is an example of the processes of biomediatisation at work 
(Briggs and Hallin 2016 ).  More than simply influencing users, the elements we have identified 
– the deployment of scientific narratives around end users, intervention effectiveness and 
epidemiological need – are constitutive of PrEP as an intervention for a ‘minority’ of the 
population, thereby shaping the boundaries of debate and the terms on which value, need 
and ultimately policy debates might be based. Noticeably absent within UK newsprint 
reporting were key global PrEP scientific events; the publication of World Health Organisation 
prevention guidelines, which recommended PrEP for men who have sex with men (WHO 
2014) and the failed clinical results from other major PrEP trials with women (Rossi 2013) 
would also play a role in configuring potential PrEP users internationally. We suggest that this 
absence in UK newsprint is indicative of key events influencing UK policy and reflects the UK 
domestic PrEP agenda, rather than engaging or ignoring the wider global scientific context. 
Ultimately, the PrEP user, configured as a cis-gendered gay and bisexual man, was 
consolidated during this time period.  While gender (and sexuality) in Pre-PROUD UK 
newsprint was non-specific and referenced a general population in the global epidemic, PrEP 
emerged as a specific intervention for gay and bisexual men. Gendered configurations of PrEP 
users have implications for how communities, health practitioners and policy makers engage 
with PrEP in real world settings.  Indeed, this articulation of PrEP users could certainly be 
implicated in NHS England’s PrEP decision, which appeared to draw on underlying (or overt) 
notions of who is a deserving (and responsible) patient (Keogh 2008). This configuration of 
PrEP users, grounded in particular gender identities and sexual practices, would become 
apparent in subsequent reporting (Twocock 2016; Mowlabocus 2019). While the genuine 
PrEP need for gay and bisexual men should be highlighted, the possibility of other users was 
lost, or significantly diminished; this reinforces existing inequalities and reflects patterns 
observed through the HIV epidemic. However, we can currently see attempts to address and 
expand this particular gendered framing of PrEP users by activists in the UK (PrEPster 2018; 
Forum. 2018).  
Strengths and limitations 
 
This research focused exclusively on newsprint media (including in print and online editions) 
and excluded social media coverage of PrEP which may have identified a more community-
informed focus. We also limited our analysis to March 2016, thereby excluding responses to 
NHS England’s policy decision and subsequent high court battles. Whereas post-March 2016 
reporting focused significantly on the rights and wrongs of the NHS decision, we were keen 
to explore how evidence was deployed and users configured in the lead up to this 
controversial decision.  Our analysis is also specific to UK newsprint and does not chart 
differential patterning of wider global PrEP implementation. Nevertheless, a strength of our 
analysis is the focus on the ways that scientific reporting can open up or close down spaces 
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in which potential PrEP users are imagined, and has implications for whether, and how, PrEP 
users may engage with and take up the interventions elsewhere.  
 
Conclusion 
 
Scientific evidence, as reported in mainstream newsprint media, can play an important role 
in shaping the public health – or technological – imaginaries (Davis 2014) in relation to trust 
of an intervention and configuring potential end users. While scientific evidence can increase 
confidence in PrEP as well as other new public health technologies, these configurations can 
close down possibilities for other users, reinforce ideas of who is a deserving patient, and play 
into wider concerns about the use of public resources for improving health and wellbeing.  
Following Triechler, we argue that there is a need to attend to language as a site in which the 
meanings of PrEP are constructed and determined. The PrEP story told in UK newsprint in the 
lead up to NHS England’s decision is only one of the many meanings of PrEP, and the role that 
it played in in this decision is both unclear and beyond the scope of this article. Nevertheless, 
charting the way in which scientific evidence and community voices in relation to public 
health need emerged during this period call attention to how media can craft and shape key 
issues in relation to public health, deserving publics and policy decisions. Our findings have 
implications for clinical and community practice in HIV prevention. Practitioners who work 
with women, trans* communities and others who may benefit from PrEP should not only be 
aware of these media framings but will need to play an active  role in responding to - and 
rebalancing - these framings to help identify and support who may benefit from PrEP.  
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Table 1. Broad thematic coding categories 
 
1. What is the main focus of the article? 
2. What is the main tone of the headline? 
3. What is the main tone of the article? 
4. Who is making comments about PrEP? 
5. How is PrEP being framed? 
6. Interpretative comments on the form and structure of the article 
7. How does the article draw on scientific evidence? 
8. What are the reported criticisms of PrEP? 
9. What are the reported benefits of PrEP? 
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Table 2. Final Sample of Newsprint Articles January 2012 – March 2016 
 
Date Newspaper Headline 
 
Priming for PROUD 
 
9/05/12 
 
Daily Mail First drug to prevent as well as treat HIV a step 
closer to approval 
17/07/12 Guardian US FDA approves first drug shown to reduce 
risk of HIV infection 
17/07/12  Guardian US approves pill that guards against HIV: 
Truvada to be available to people at extreme 
risk Aids support group labels move 
‘completely reckless’ 
17/07/12  Daily Mail The first drug which can PREVENT HIV: Pills 
reduce risk by up to 75% in at risk heterosexual 
couples 
13/06/13  Daily Mail  New AIDS prevention pill could cut infection 
rates in IV drug users by 50% 
10/02/14  The Times Trial of pill to prevent HIV could lead to a risk in 
promiscuity  
25/04/14  Daily Mail  More mixed-status couples conceiving children 
without protection as new treatments 
minimise the risk of infection 
17/05/14  Daily Mail  Pressure grows on NHS to make new HIV 
wonder drug available for those at risk  
17/05/14  The Independent 
 NHS urged to prescribe daily HIV pill to gay men 
8/09/14  Daily Mirror 
 Revolution that could halt epidemic of HIV 
30/09/14 Guardian 
 HIV protection in a pill for those at risk 
17/10/14  The Times Coming soon: the daily pill that can protect 
against HIV 
17/10/14  Daily Mail  ‘Wonder drug’ which can reduce HIV risk by 
92% could be offered on the NHS 
18/10/14  Guardian Analysis: An HIV prevention pill is at hand, but 
will it be left untaken?  
30/10/14  The Independent  Revolutionary new anti-HIV pill shown to work 
when taken ‘on demand’  
 
Post PROUD 
 
24/02/15  The Independent HIV pill: The logic of paying £500 a month so 
gay men don’t have to wear condoms 
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24/02/15  Telegraph Scientists hail daily pill that cuts HIV risk by 87 
per cent  
25/02/15  The Sun 
 DOCS’ PLEA FOR HIV PILL ON NHS 
25/02/15  The Independent Scientists hail daily pill that protects against 
HIV infection;  
25/02/15  The Independent The logic of paying £500 a month so gay men 
don’t have to wear condoms  
25/02/15  The Independent HIV pill: Scientists hail discovery of ‘game-
changer’ that cuts the risk of infection among 
gay men by 86% 
25/02/15  Guardian Daily pill Truvada cuts spread of HIV by 86% 
study shows  
25/02/15 Daily Telegraph 
 Before-and-after pill cuts HIV risk 
25/02/15  The Times 
 Daily pill reduces HIV risk by 90% 
25/02/15  
 
The Scotsman HIV game-changer as drug protects healthy gay 
men 
26/02/15  Daily Mail HEALTHY GAY MEN SHOULD BE GIVEN £440-A-
YEAR HIV PILLS ON THE NHS’ 
26/06/15  The Independent Pride in London: NHS to come under pressure 
to provide ‘miracle’ HIV prevention pill  
27/06/15  The Independent  
 Pride hears calls for NHS to introduce HIV pill 
10/10/15  The Independent Daily pill that lowers HIV risk ‘could save NHS 
millions’ 
10/10/15  The Independent NHS ‘cannot afford to ignore game-changing 
HIV drug’, experts say  
11/10/15  The Independent Cheap at the price; Editorial The NHS should 
fund prescription of a new Aids treatment 
11/10/15  The Independent Aids vanquished: A costly new pill promises to 
prevent HIV infection 
24/10/15  Daily Mail  Could drugs to prevent HIV actually INCREASE 
the risk of infection by encouraging people not 
to use condoms? 
16/11/16  Daily Mail Once-a-day pill ‘DOES prevent HIV in the real 
world’: PrEP drugs ‘are effective in protecting 
health gay men from infection’ 
2/12/15  The Herald HIV charity in call for NHS to prescribe drug 
 
11/12/15  Guardian The choice to take the HIV prevention pill has 
nothing to do with sluttiness  
14/01/16  The Times 
 Fears HIV pill could encourage risk behaviour 
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14/01/16  Telegraph Daily HIV pill for men ‘would prevent 10 000 
new cases in UK by 2020’  
14/01/16  Daily Mail  Daily pill to prevent HIV may be offered to 
thousands of men on the NHS after trials 
showed it could cut risks by 60% 
25/02/16  Daily Mail  Gay man taking daily HIV prevention pill 
contracts resistant strain of the virus – in first 
recorded case of PrEP failing 
21/03/16  Daily Mail Could a monthly injection prevent HIV? Single 
shot of PrEP drugs is ‘as effective as taking pills 
twice a day’ 
25/03/16  Guardian 
 
NHS England stalls plan for HIV prevention 
drugs  
22/03/16  The Times 
 Pill to stop HIV will not get funding 
22/03/16  Daily Mail  Charities slam NHS England and ‘U-turn’ over 
plans to roll out ‘HIV wonder drug’ 
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Table 3. Overview of findings according to theme and time period 
 
 Ir/responsible citizens Public health imperative 
 
 
 
Priming for PROUD 
July 2012 – January 
2015 
 
 
• PrEP users as potentially 
irresponsible actors 
• Risk of STIs/reduced 
condom use 
• Mixed or unsupportive 
community responses  
• PrEP effectiveness in ‘real 
world’ is uncertain 
 
 
• New infections globally with 
increased focus on 
vulnerable women and/or 
general population 
• PrEP as expensive/costly 
 
 
 
 
Post PROUD 
February 2015 – 
March 2016 
 
 
• PrEP users as responsible  
• An absence of ‘risky’ sexual 
practices 
• Limited or stable STIs 
• PrEP will work/certainty of 
intervention 
 
 
• PrEP is a ‘game-changing’ 
intervention 
• Gay & bisexual men in UK at 
most risk of HIV and in real 
need of new prevention 
tools 
• Limited or no discussion of 
PrEP for other groups  
• PrEP is a cost-effective 
intervention 
 
 
